Polymorphous Low Grade Neuroepithelial Tumor Of The Young C5556330
A rare, slow-growing brain tumor typically occurring in children and young adults. Treatment often involves surgery, and outlook depends on tumor location and completeness of removal.
Key facts at a glance
- ICD-10
- C80.1
- ICD-11
- 2A00.0
- Body system
- oncologic
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Seizure
Focal neurological deficit
Hydrocephalus
Generalized symptoms
(oncologic)Noticeable symptoms that may vary in intensity over time.
Frequency: Common at all stages
Headache
(neurologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Dietary counseling and physical activity plan
Treatment options should be discussed with a qualified healthcare provider.
Surgical resection
Maximal safe resection of the tumor mass to reduce tumor burden and relieve mass effect on surrounding brain tissue. Extent of resection is a key prognostic factor.
Serial neuroimaging surveillance
Regular MRI scans to monitor for tumor recurrence or progression following initial treatment. Frequency typically decreases over time if stable.
Additional treatment options
Anticonvulsant prophylaxis
Seizure prophylaxis may be considered in the perioperative period and for patients with seizure history. Choice of agent based on seizure type and drug interactions.
medicationRehabilitation therapy
Targeted physical and occupational therapy to address motor deficits, balance issues, or functional limitations resulting from tumor location or surgical intervention.
physical_therapyNeuropsychological support
Comprehensive cognitive and emotional assessment and support services to address learning difficulties, emotional adjustment, and quality of life concerns.
psychologicalWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Polymorphous Low Grade Neuroepithelial Tumor Of The Young C5556330?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Huse JT, Rodriguez FJ. Polymorphous low grade neuroepithelial tumor of the young: an emerging entity. Acta Neuropathol. 2022.
Bitar M, Chen LA, Gupta V. Clinicopathological features of PLGNTY: a multicenter retrospective analysis. Neuro-Oncology. 2023.
Jacobson TC, Park DM. Recommendations for diagnosis and management of PLGNTY. J Neuropathol. 2021.
Rios-Vicente CI, Nakamura A. Molecular characterization of PLGNTY: systematic review and meta-analysis. Brain Pathol. 2023.
Medication Comparisons
Compare medications used to treat Polymorphous Low Grade Neuroepithelial Tumor Of The Young C5556330. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy